annual Report 2009 - STRATEC Biomedical AG

(7) (8) (9) (10) (11) (12) (13) (14)
Granted in 2007 2008
Subscription price per share* in u 24.76 22.69 22.82 20.60 21.64 17.37 11.98 12.28
Subscription price per share following capital increase
from company funds (bonus shares)* in u 24.76 22.69 22.82 20.60 21.64 17.37 11.98 12.28
Expected share price volatility in % 46.8 45.0 43.6 42.1 42.0 48.81 55.82 55.66
Expected dividend yield in % 0.60 0.60 0.60 0.70 0.70 1.00 1.50 1.50
Risk-free interest rate in % 4.02 4.50 4.50 4.22 4.28 3.88 3.88 3.56
Assumed turnover of personnel
entitled to subscribe in % 3.50 0 3.50 3.50 3.50 5.00 5.00 5.00
Allocable personnel expenses in u thousand 2 243 1 7 4 4 186 9
* Following the capital increase from company funds on July 14, 2006 (1:2.9942188) 2.9942188 ordinary shares with a nominal value of u 1.00 each are granted for the
subscription prices for Plans (1) to (3) depicted above, to the extent that these had not been exercised by July 14, 2006.
Granted in 2009
(15) (16) (17) (18) (19)
Subscription price per share* in u 11.62 9.23 15.63 20.38 22.10
Subscription price per share following capital increase
from company funds (bonus shares)* in u 11.62 9.23 15.63 20.38 22.10
Expected share price volatility in % 55.19 55.19 59.81 55.48 48.04
Expected dividend yield in % 1.5 1.5 1.5 1.5 1.5
Risk-free interest rate in % 3.13 3.02 3.47 3.21 3.22
Assumed turnover of personnel
entitled to subscribe in % 5.0 5.0 16.5 5.0 5.0
Allocable personnel expenses in u thousand 1 72 129 20 4
* Following the capital increase from company funds on July 14, 2006 (1:2.9942188) 2.9942188 ordinary shares with a nominal value of u 1.00 each are granted for the
subscription prices for Plans (1) to (3) depicted above, to the extent that these had not been exercised by July 14, 2006.
Stock option program II (SOP II)
Stock option program II was adopted by the Annual General Meeting on May 28, 2003. The option rights set out below
were allocated on the basis of this resolution (each option right entitles the bearer to acquire one STRATEC share; from
July 14, 2006: 2.9942188 shares):
(1) / 2 nd tranche of SOP II
A total of 70,000 option rights were issued to employees in April 2004. Prior to the execution of the capital increase
from company funds (bonus shares), a total of 10,394 shares were issued to employees in the 2006 financial year
following the exercising of 10,394 option rights. After the execution of the capital increase from company funds, a total
of 68,639 shares were issued to employees following the exercising of 22,926 option rights. In 2007, 80,654 shares were
issued to employees following the exercising of 26,941 option rights. In 2008, 7,698 shares were issued to employees
following the exercising of 2,572 option rights. In 2009, 3,853 shares were issued to employees following the exercising
of 1,287 option rights. A total of 5,880 option rights entitling their bearers to subscribe a maximum total of 17,606 shares
therefore remained as of December 31, 2009.
(2) / 4 th tranche of SOP II
A total of 11,000 option rights were issued to employees of STRATEC AG in July 2005. Following the exercising of
5,500 option rights, 16,466 shares were issued in the 2007 financial year. 4,000 option rights lapsed in 2007. Following
the exercising of 750 option rights, 2,245 shares were issued in 2008. In 2009, 2,244 shares were issued following the
exercising of 750 option rights. All option rights in this tranche have thus been exercised.
80 stratec Annual Report 2009